BCM
STAA icon

BlueCrest Capital Management’s STAAR Surgical STAA Stock Holding History

BlueCrest Capital Management’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,417
Closed -$212K – 1376
2018
Q3 		$212K Buy
+4,417
New +$181K 0.01% 1240

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlueCrest Capital Management's STAA Position: Q4 2018 in Review

BlueCrest Capital Management sold out of STAAR Surgical (STAA) in Q4 2018, closing a stake of 4,417 shares — an estimated $212K sold.

BlueCrest Capital Management first reported a position in STAA in Q3 2018 and held it in 1 quarter. The position peaked at $212K in Q3 2018. 181 funds tracked by Wall St. Rank hold STAA as of Q4 2018.

  • BlueCrest Capital Management reported no remaining STAAR Surgical position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 4,417 STAAR Surgical shares in Q4 2018, an estimated $212K.
  • BlueCrest Capital Management first reported a position in STAAR Surgical in Q3 2018 and held it in 1 quarter.
  • BlueCrest Capital Management's STAAR Surgical position peaked at $212K in Q3 2018.
  • 181 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.